Wouldn't a good result with Nyuni #2 negate the desire by wavering shareholders to accept our good assets being diluted?
Actually I can't see any result for Nyuni #2 shifting favour towards the Zeta acquisition for anyone besides those with some sort of commercial/financial interest in the deal going ahead.
Key run the possibility of a class action if the deal goes ahead, especially if the vote is very close and the abstaintations are quite low.
- Forums
- ASX - By Stock
- KEY
- key management
key management, page-39
Featured News
Add KEY (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.262M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
KEY (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online